Follow Warren Buffett Into These 3 Pharma Companies
Warren Buffett is regarded as one of the world's quintessential value investors. Following the teachings of his business school professor Benjamin Graham, Buffett has made a legendary career for himself by buying companies for less than what he sees as their true value. He recently made purchases of three large-cap pharmaceutical companies, AbbVie (NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY), and Merck (NYSE:MRK). Let's explore the ways they offer a great opportunity for everyday investors, too.
Spun off from Abbott Labs in 2013, AbbVie is one of the newer pharmaceutical companies on the market. However, the young company's management team wasted no time developing breakthrough drugs and driving sales to generate huge returns for shareholders. One of its more recent successes, Humira (for Crohn's disease), was the world's best-selling drug in 2020, with revenue of nearly $20 billion. This and several other leading products, including Skyrizi (for psoriasis) and Rinvoq (for rheumatoid arthritis), have helped drive AbbVie's stock price up nearly 228% since inception.
Source Fool.com